Literature DB >> 15140773

Hypothalamic-pituitary-adrenal axis function in ankylosing spondylitis.

R Imrich1, J Rovensky, M Zlnay, Z Radikova, L Macho, M Vigas, J Koska.   

Abstract

OBJECTIVE: To assess basal function and responsiveness of the hypothalamic-pituitary-adrenal (HPA) axis in patients with ankylosing spondylitis during dynamic testing.
METHODS: Insulin induced hypoglycaemia (IIH) (Actrapid HM 0.1 IU/kg, as intravenous bolus) was induced in 17 patients and 11 healthy controls matched for age, sex, and body mass index. Concentrations of glucose, adrenocorticotrophic hormone (ACTH), cortisol, insulin, dehydroepiandrosterone sulphate (DHEAS), 17alpha-hydroxyprogesterone, interleukin 6 (IL-6), and tumour necrosis factor alpha (TNFalpha) were determined in plasma.
RESULTS: Comparable basal cortisol levels were found in the two groups, with a trend to be lower in ankylosing spondylitis. In the ankylosing spondylitis group, there were higher concentrations of IL-6 (mean (SEM): 16.6 (2.8) pg/ml v 1.41 (0.66) pg/ml in controls; p<0.001) and TNFalpha (8.5 (1.74) pg/ml v 4.08 (0.42) pg/ml in controls; p<0.01). Glucose, insulin, ACTH, DHEAS, and 17alpha-hydroxyprogesterone did not differ significantly from control. The IIH test was carried out successfully in 11 of the 17 patients with ankylosing spondylitis, and the ACTH and cortisol responses were comparable with control. General linear modelling showed a different course of glycaemia (p = 0.041) in the ankylosing spondylitis patients who met the criteria for a successful IIH test compared with the controls.
CONCLUSIONS: The results suggest there is no difference in basal HPA axis activity and completely preserved responsiveness of the HPA axis in patients with ankylosing spondylitis. The interpretation of the different course of glycaemia during IIH in ankylosing spondylitis requires further investigation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15140773      PMCID: PMC1755016          DOI: 10.1136/ard.2003.006940

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  24 in total

1.  Immunoreactive insulin levels in ankylosing spondylitis.

Authors:  F J Jiménez-Balderas; J L Solís; G Mintz
Journal:  Arch Invest Med (Mex)       Date:  1991 Apr-Jun

Review 2.  Androgens and ankylosing spondylitis: a role in the pathogenesis?

Authors:  E J Giltay; D van Schaardenburg; L J Gooren; C Popp-Snijders; B A Dijkmans
Journal:  Ann N Y Acad Sci       Date:  1999-06-22       Impact factor: 5.691

3.  Sex hormones in spondylarthropathies. A study in 57 patients.

Authors:  D Arniaud; J P Mattei; J Boyer; H Roux
Journal:  Rev Rhum Engl Ed       Date:  1998-01

4.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

5.  Testicular function in active ankylosing spondylitis. Therapeutic response to human chorionic gonadotrophin.

Authors:  R Tapia-Serrano; F J Jimenez-Balderas; S Murrieta; C Bravo-Gatica; R Guerra; G Mintz
Journal:  J Rheumatol       Date:  1991-06       Impact factor: 4.666

6.  Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids.

Authors:  M Cutolo; L Foppiani; C Prete; P Ballarino; A Sulli; B Villaggio; B Seriolo; M Giusti; S Accardo
Journal:  J Rheumatol       Date:  1999-02       Impact factor: 4.666

7.  Impaired glucose handling in active rheumatoid arthritis: relationship to the secretion of insulin and counter-regulatory hormones.

Authors:  K L Svenson; G Lundqvist; L Wide; R Hällgren
Journal:  Metabolism       Date:  1987-10       Impact factor: 8.694

8.  Low blood and synovial fluid levels of sulpho-conjugated steroids in rheumatoid arthritis.

Authors:  M Hedman; E Nilsson; B de la Torre
Journal:  Clin Exp Rheumatol       Date:  1992 Jan-Feb       Impact factor: 4.473

9.  Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity.

Authors:  J Gratacós; A Collado; X Filella; R Sanmartí; J Cañete; J Llena; R Molina; A Ballesta; J Muñoz-Gómez
Journal:  Br J Rheumatol       Date:  1994-10

10.  Evidence for peripheral impaired glucose handling in patients with connective tissue diseases.

Authors:  G Paolisso; G Valentini; D Giugliano; G Marrazzo; R Tirri; M Gallo; G Tirri; M Varricchio; F D'Onofrio
Journal:  Metabolism       Date:  1991-09       Impact factor: 8.694

View more
  3 in total

1.  Impaired hypothalamo-pituitary-adrenal axis in patients with ankylosing spondylitis.

Authors:  L Kebapcilar; O Bilgir; A Alacacioglu; Y Yildiz; A Taylan; R Gunaydin; A Yuksel; B Karaca; I Sari
Journal:  J Endocrinol Invest       Date:  2009-07-20       Impact factor: 4.256

2.  Increased expression of Toll-like receptor 4 in peripheral blood leucocytes and serum levels of some cytokines in patients with ankylosing spondylitis.

Authors:  Z-X Yang; Y Liang; Y Zhu; C Li; L-Z Zhang; X-M Zeng; R-Q Zhong
Journal:  Clin Exp Immunol       Date:  2007-04-25       Impact factor: 4.330

3.  Serum markers associated with clinical improvement in patients with ankylosing spondylitis treated with golimumab.

Authors:  Carrie Wagner; Sudha Visvanathan; Jürgen Braun; Désirée van der Heijde; Atul Deodhar; Benjamin Hsu; Michael Mack; Michael Elashoff; Robert D Inman
Journal:  Ann Rheum Dis       Date:  2011-10-28       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.